Arcadia Biosciences, Inc.
$1.11
▼
-3.42%
2026-04-21 09:10:00
www.arcadiabio.com
NCM: RKDA
Explore Arcadia Biosciences, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.29 M
Current Price
$1.11
52W High / Low
$6.71 / $0.89
Stock P/E
—
Book Value
$3.02
Dividend Yield
—
ROCE
-222.75%
ROE
-45.14%
Face Value
—
EPS
$-1.71
Exp Qtr EPS
—
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
8
Beta
0.72
Debt / Equity
0
Current Ratio
3.09
Quick Ratio
2.5
Forward P/E
-1.03
Price / Sales
0.56
Enterprise Value
$-1.85 M
EV / EBITDA
0.35
EV / Revenue
-0.38
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Darling Ingredients Inc. | $60.49 | 154.15 | $9.61 B | — | 4.47% | 1.52% | $64.9 / $28.32 | $29.94 |
| 2. | Freshpet, Inc. | $68.12 | 24.4 | $3.39 B | — | 4.45% | 12.29% | $89.8 / $46.76 | $24.68 |
| 3. | Above Food Ingredients Inc. | $0.71 | — | $51.19 M | — | 396.47% | 244.4% | $6.56 / $0.32 | $-0.43 |
| 4. | LifeVantage Corporation | $5.13 | 7.77 | $61.08 M | 3.51% | 27.27% | 25% | $15 / $3.9 | $2.58 |
| 5. | Bridgford Foods Corporation | $7.28 | — | $68.89 M | — | -15.01% | -10.83% | $8.74 / $7 | $12.64 |
| 6. | Herbalife Ltd. | $16.98 | 7.69 | $1.76 B | — | 27.13% | -34.69% | $20.4 / $6.2 | $-4.99 |
| 7. | BellRing Brands, Inc. | $16.48 | 10.34 | $1.89 B | — | 54.3% | -65.54% | $79.57 / $14.19 | $-4.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.9 M | 1.3 M | 1.46 M | 1.2 M | 1.22 M | — |
| Operating Profit | -1.38 M | -1.41 M | -5.99 M | -1.22 M | -2.28 M | — |
| Net Profit | -1.34 M | 0.86 M | -4.46 M | 2.6 M | -4.06 M | — |
| EPS in Rs | -0.65 | 0.42 | -2.17 | 1.26 | -1.98 | -1.18 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.86 M | 5.04 M | 4.45 M | 7.42 M |
| Operating Profit | -9.99 M | -7.61 M | -6.02 M | -15.23 M |
| Net Profit | -2.34 M | -7.04 M | -13.98 M | -15.38 M |
| EPS in Rs | -1.14 | -3.42 | -6.8 | -7.48 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.55 M | 13.52 M | 19.7 M | 28.92 M |
| Total Liabilities | 2.41 M | 7.29 M | 7 M | 8.02 M |
| Equity | 4.14 M | 6.22 M | 12.84 M | 21.03 M |
| Current Assets | 6.36 M | 9.24 M | 14.97 M | 25.4 M |
| Current Liabilities | 2.06 M | 2.56 M | 3.59 M | 4.21 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -4.74 M | -9.63 M | -15.29 M | -13.98 M |
| Investing CF | 0.75 M | 7.34 M | -4.34 M | 1.42 M |
| Financing CF | 0.01 M | 0.01 M | 5.51 M | 4.52 M |
| Free CF | -4.74 M | -9.64 M | -15.3 M | -14.05 M |
| Capex | — | -0.02 M | -0.01 M | -0.07 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.27% | -39.96% | — | — |
| Earnings Growth % | 49.66% | 9.07% | — | — |
| Profit Margin % | -139.5% | -313.9% | -207.28% | — |
| Operating Margin % | -150.88% | -135.11% | -205.28% | — |
| Gross Margin % | 41.27% | 51.19% | 17.75% | — |
| EBITDA Margin % | -148.64% | -128.67% | -198.83% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-03-01 | 1:0.025 |